BLT 0.00% 2.6¢ benitec biopharma limited

Calimmune Gen2

  1. 4,015 Posts.
    lightbulb Created with Sketch. 127
    Geoff Symonds has already flagged that Transcriptional Gene Silencing is the next strategy of Calimmune's HIV program. He works closely with the Kirby Institute in NSW. Here is their latest paper on shrna TGS of HIV.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.